Peer-led HIV prevention support for women
Part of Immune system & allergy, Infections clinical trials.
This study tests whether support from trained peers can help women choose and stick with an HIV prevention method that fits their life. It aims to make prevention easier to access and use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years old or older
- You are female (assigned female at birth)
- You tested negative for HIV
- You are at higher risk of HIV (for example, eligible for PrEP/PEP or working in a bar or guesthouse)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
This research tests a tool that helps women and their partners make informed decisions about PrEP (a daily pill that prevents HIV). The study involves healthcare workers, patients, and leaders in Uganda to improve how women choose and use HIV prevention.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This trial tests a peer-led education and counseling program to help people with TB and HIV stick with their treatment. It may help improve understanding, motivation, and day-to-day adherence to medications.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.